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Abstract
Genome-wide association studies have found thousands of common genetic variants associated with a wide variety of
diseases and other complex traits. However, a large portion of the predicted genetic contribution to many traits remains
unknown. One plausible explanation is that some of the missing variation is due to the effects of rare variants. Nonetheless,
the statistical analysis of rare variants is challenging. A commonly used method is to contrast, within the same region (gene),
the frequency of minor alleles at rare variants between cases and controls. However, this strategy is most useful under the
assumption that the tested variants have similar effects. We previously proposed a method that can accommodate
heterogeneous effects in the analysis of quantitative traits. Here we extend this method to include binary traits that can
accommodate covariates. We use simulations for a variety of causal and covariate impact scenarios to compare the
performance of the proposed method to standard logistic regression, C-alpha, SKAT, and EREC. We found that i) logistic
regression methods perform well when the heterogeneity of the effects is not extreme and ii) SKAT and EREC have good
performance under all tested scenarios but they can be computationally intensive. Consequently, it would be more
computationally desirable to use a two-step strategy by (i) selecting promising genes by faster methods and ii) analyzing
selected genes using SKAT/EREC. To select promising genes one can use (1) regression methods when effect heterogeneity
is assumed to be low and the covariates explain a non-negligible part of trait variability, (2) C-alpha when heterogeneity is
assumed to be large and covariates explain a small fraction of trait’s variability and (3) the proposed trend and
heterogeneity test when the heterogeneity is assumed to be non-trivial and the covariates explain a large fraction of trait
variability.
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Introduction
Genome-wide association studies (GWAS) have found many
genetic variants associated with a wide range of traits [1–4]. There
is evidence that for most traits, common variants identified in
GWAS collectively explain a smaller fraction of phenotypic
variability than expected [2,5,6]. Consequently, a considerable
portion of the genetic contribution to phenotypic variability
remains unknown [7]. One possible explanation is that rare
genetic variation, which is poorly assayed or tagged by current
GWAS platforms, may account for much of that missing variation
[8]. There are a growing number of examples of rare variants
having large effects on complex traits [9–11].
Advances in short-read sequencing technology have made the
investigation of low frequency variants increasingly cost-effective.
In turn, the availability of large-scale sequencing studies are
spurring the development of statistical methodology for their
analysis. The first wave of methods applied to the analysis of rare
variation collapsed the genotypes for all rare variants (RVs) from
a defined genetic unit, e.g. a gene, into a single carriage status
variable. Subsequently, the frequency of RV carriers was
contrasted between cases and controls (or extreme tails of
a quantitative trait distribution) [12]. The collapsing method can
also be performed in a regression setting by treating the binary
trait as a dependent variable and regress it on carriage status or on
carriage status and covariates [13]. While these methods can
accommodate covariates, due to collapsing they lose power when
RV effects are heterogeneous. This is a concern since, we know
that the effects of RVs in many genes can be heterogeneous, e.g.
PCSK9 [14,15] and CASR [16].
The possibility of effect heterogeneity led researchers to
develop methods that can accommodate such a scenario. We
previously developed methods for quantitative traits which allow
for the heterogeneity of RV effects [17]. To accommodate the
fact that RVs in the same gene can result in increased or
decreased phenotypic values, our method tests if RV carriers
have increased square deviations of phenotype from its mean.
One of the first methods to test for association between binary
traits and RVs in the presence of both risk and protective
variants was the weighted sum approach of Ionita-Laza et al.
[18]. A somewhat similar approach is the C-alpha test that,
similar to the above weighted sum approach, accommodates
heterogeneity but does not accommodate covariates [19]. C-
alpha is a test of extra-binomial variance in the proportion of
PLoS ONE | www.plosone.org 1 August 2012 | Volume 7 | Issue 8 | e42530
cases within each variant. Subsequently, kernel based adaptive
clustering (KBAC) was proposed to accommodate both hetero-
geneity and covariates [20]. A similarity regression approach was
proposed to jointly analyze common and rare variants in the
presence of heterogeneous effects [21]. Lately, there were also
proposals for methods which can test a wide range of statistical
models in the presence of covariates and effect heterogeneity.
Due to the wide range of models, these methods generalize many
previous approaches. One of the first of these general methods
was the Sequence Kernel Association Test (SKAT) [22]. SKAT
uses a kernel regression machine to model the genotype
phenotype association. A related general approach is the
Estimated REgression Coefficients (EREC) method [23]. EREC
uses a general linear model framework to generalize most RV
tests.
We extend the methods we previously developed for quantita-
tive traits to the analysis of binary traits in the presence of
covariates. The performance of the proposed and competing
methods is evaluated by a simulation design with varying
heterogeneity levels and covariate influence. Based on the results
Table 1. Simulation design parameters.
Parameter Name Parameter Design levels
Sample size n 1000 cases and 1000 controls
Prevalence K 0.1
Fraction of trait’s variability explained by covariate (%) Rsq [14]
True damage class Dt [30]
Effect size (SDs) d 0 to 1 in steps of 0.05
Heterogeneity parameter f {0.5, 0.8, 1}
Percentiles coding sequence lengths (coding base pairs) CDS {10, 50, 90} ({361,1209, 4057})
Number simulations at each design level m 250 for the empirical power (d.0) 25,000 for the size of the test (d= 0)
doi:10.1371/journal.pone.0042530.t001
Figure 1. Relative size of the test* for 1000 cases and 1000 controls at a type I error of 1023. The size of the test estimated empirically
from 25,000 simulations. Black, turquoise and red circles correspond to gene CDS equal to 10, 50, and 90 percentiles of the human gene CDS
distribution, respectively. Methods: RCS – (logistic) regression on carriage status, RCS-C – (logistic) regression on carriage status and covariates, CA –
C-alpha test, CA-P – C-alpha test with permutations, TH – test of trend and heterogeneity, SK – SKAT, SK-R – SKAT with (parametric bootstrap)
resampling, ER – EREC. *The ratio of the size of the test to the nominal type I error rate.
doi:10.1371/journal.pone.0042530.g001
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we make recommendations on how to choose the most desirable
method (or combination of methods) based on the influence of
covariates and the potential level of heterogeneity of RV effects.
Methods
We previously developed a trend and heterogeneity (TH) test
for quantitative traits which accommodates heterogeneity [17].
Such a test was developed because in practice the true causal
model realistically lies somewhere between homogeneity and
complete heterogeneity (the effect of the variant is equally likely to
be positive or negative). To develop a powerful test for such
circumstances, we start from the second moment equality:
E(Z2)~m2zs2, where m is the mean and s2 is the variance of
random variable Z. Therefore, the square of quantitative trait, Z,
naturally incorporates information about both the trend (i.e. the
mean), and the heterogeneity (i.e. the variance). Thus, assuming
Zi, i=1,…m, are the quantitative phenotypes of RV carriers, we
proposed the trend and heterogeneity statistic: TH~
Pm
i~1
Z2i . The
statistical significance of TH is computed very fast empirically by
resampling Zi of the m RV carriers from the larger set of
quantitative values for the entire sample.
TH can be adapted to binary traits in a straightforward manner
by: (1) using a logistic regression of the binary trait on the
covariates to obtain Pearson’s residuals and (2) treating Pearson’s
residuals as a quantitative trait in a TH test (see [24] for a similar
treatment). However, by not analyzing covariates and carriage
status simultaneously, the straightforward TH adaption does not
fully use the information available.
To assess the performance of the proposed method we compare
its performance to the performance of several alternatives. In this
study we include simple regression, C-alpha (CA), SKAT and
EREC methods. The regression methods use a logistic regression
of the binary trait on carriage status (RCS) or on carriage status
and covariates (RCS-C). For CA (our implementation based on
code from Dr. Kathryn Roeder), we present the size of the test
based on i) asymptotic p-values (CA) and ii) permutation p-values
(CA-P). SKAT (version 0.72) performance was assessed at the
default settings (i.e. linear kernel, etc.) using i) asymptotic p-values
(SK) and ii) p-values derived from parametric bootstrap resam-
pling (SK-R). EREC (SCORE-Seq version 2.0) performance was
assessed at the default settings with the exception of the minimum
allele count. Because many variants had only a few minor alleles
and we wanted to include all variants in our analyses, we set
EREC’s minor allele count parameter to zero. EREC statistical
significance is assessed adaptively from up to one million
Figure 2. Empirical power at a type I error of 1023 for Scenario 1 under homogeneity (j=1). The power estimated from 250 simulations.
The covariate is assumed to be explaining a fraction (Rsq) equal to 0, 10 or 20% of the variability in binary trait. Power is presented for 10% (black),
50% (turquoise) and 90% (red) percentiles of CDS length. See Fig. 1 for background and abbreviation.
doi:10.1371/journal.pone.0042530.g002
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permutations. While KBAC should be able to accommodate
heterogeneity and covariates, the software implementing the
method was not available at the time we carried out our initial
simulations. Consequently, we did not include KBAC in this study.
We use a simulation design (Table 1) to compare the
performance of the above mentioned methods when they are
used for a gene level analysis of non-synonymous RVs. We assume
a sample of 1000 cases and 1000 controls for a binary trait with
a prevalence K=10%. A potentially relevant covariate was
assumed to explain a fraction (Rsq) equal to 0%, 15%, or 30%
of binary trait variability. We simulate data sets by (1) assuming
that the probability of carrying an RV is 1% per 500 bp of coding
sequence (i.e. the larger genes contain more RVs) [17,25] (2)
simulating a latent and normally distributed variable based on the
RVs in each subject (see [17]), (3) using the latent variable in
a threshold model to generate a binary trait with prevalence K and
(4) sampling the required number of cases and controls.
Similar to our previous work [17], we define RVs as having
a minor allele frequency less than 0.5%. Since the expected
number of rare alleles per subject depends on the length of the
coding sequence (CDS), in each simulation we generate variant
sites (SNPs) having their frequencies independently drawn from
a Wright’s distribution [18,26] until their cumulative minor allele
frequency is closest to the expected probability of carrying a rare
allele in the gene under investigation (i.e. 1% for each 500 CDS
bps [17]). For Wright’s distribution,
f pð Þ~kpbs{1 1{pð Þbn{1es 1{pð Þ (where p is the mutation allele
frequency), ln bsð Þ is assumed to be uniform between ln(0:1) and
ln(3), ln(bn) uniform between ln 0:001ð Þ and ln 0:01ð Þ and s is
assumed to be 0 with probability 0.5 and distributed as a uniform
between 0 and 20 with probability 0.5 [26]. Large scale
sequencing studies show that the Wright formula with our choice
of parameters underestimates the occurrence of very rare variants
in human populations [27]. However, there is not a substantial
difference in frequencies of rarer variants between our simulations
and applied sequencing studies. Consequently, the conclusions
derived from our simulation design are likely to be very similar to
those derived from a design based on real sequencing data.
Let Dt be the (true) deleteriousness class of RVs, i.e. the
deleterious class of the RV a subject carries in a gene and zero
otherwise. (For the unlikely case of multiple RVs in the same gene
and subject, we retain only the most deleterious variant.) Dt is
assumed to be a numerical variable with integer levels of 0 (for
subjects not possessing RVs) to 3 (very deleterious). For each
variant, Dt is sampled from 0 to 3, with the probability vector
(0.26,0.16,0.36,0.22), as estimated from population genetics studies
[28] (see Table 4 of Boyko et al. [28] or Table S1 in
Supplementary Material). To facilitate the investigation of various
heterogeneity models, each variant was also assigned a sign,
U[f{1,z1g, for its effect on trait, i.e. each variant was simulated
Figure 3. Empirical power at a type I error of 1023 for Scenario 1 under heterogeneity (j=0.5). See Fig. 1 and 2 for background and
abbreviation.
doi:10.1371/journal.pone.0042530.g003
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to be either risk increasing (+1) with probability f[½1
2
,1 or risk
decreasing (21) with probability 1{f. f~1 corresponds to
homogeneity, f~ 1
2
corresponds to complete heterogeneity and
intermediate values of f correspond to varying levels of partial
heterogeneity. We note that bothDt and Uare variant specific, i.e.
they have the same value for all carriers of the variant. Let G be
the variable denoting RV carriage status, i.e. the indicator of the
deleterious class being nonzero 2 I[Dt.0]. With these assump-
tions we model the latent trait, Z, as follows:
Z~Uf(Dt)dza  Cze
where
U~
1 with probability f
{1 with probability 1{f

is the sign of the effect for the rare variant, f[½1
2
,1 is the
heterogeneity parameter controlling the relative frequency of
mutations increasing the trait levels, f(Dt)~Dt for linear
(Scenario 1) model in which the true damage class reflects effect
size and f(Dt)~G for homogeneity of the effect magnitude model
(Scenario 2). d is the difference in phenotype means between two
adjacent levels of the explanatory variable (in standard deviations).
The parameter a is the coefficient of the covariate, C, which
explains Rsq of the binary trait heritability. The error term, e, is
assumed to be normally distributed. A subject with a latent
variable, Z, is assigned to be a i) case if Z is above the threshold
defined by the 12K percentile (i.e. 90% for our choice of
prevalence) of the latent trait distribution and ii) control if Z is
below this threshold.
For every gene level analysis, the number of rare variants, and
therefore power, depends on the length of CDS. Consequently, the
power and size of the test for each method was estimating
assuming CDS are equal to the {10, 50, 90} percentile (i.e.
{361,1209, 4057} coding base pairs) of the CDS for human genes
as estimated [17] from RefSeq [29].
Results
Under the null hypothesis of no association between trait and
RVs, all methods with the exception of asymptotic distribution
CA control the type I error (Fig. 1). Methods that control the
type I error show a slight tendency to be more conservative at
short gene lengths, likely due to the discreteness of the
distribution. Thus, for a fair comparison between methods, we
estimate the power of CA, TH, SKAT and EREC under the
alternative hypothesis by using permutation (resampling for
SKAT) tests. Because they need to recompute the statistics for
Figure 4. Empirical power at a type I error of 10 for Scenario 1 under partial heterogeneity (j=0.8). See Fig. 1 and 2 for background and
abbreviation.
doi:10.1371/journal.pone.0042530.g004
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each permutation, the running time for permutation based
SKAT and EREC inference was almost two orders of
magnitude larger than the running time of TH and CA-P.
The power was assessed under three heterogeneity settings:
homogeneity (j=1, Fig. 2), heterogeneity (j=0.5, Fig. 3) and
partial heterogeneity (j=0.8, Fig. 4). The qualitative features of
power under the two scenarios (linear and magnitude homogene-
ity) are quite similar, which suggests that collapsing in a regression
framework is actually relatively robust to heterogeneity in the
magnitude of effects. Due to this similarity, we present only the
power under the scenario of effect linearity. Because RCS-C has
equal power to RCS when the covariate explains 0% (i.e.
Rsq= 0%) of the trait and it is greater than RCS when Rsq is
15% or greater, we omit RSC from the presentation of power
estimates.
As expected, RCS-C has the greatest power under homoge-
neity (j=1), except probably at the shorter gene lengths where
SK and ER perform better. The different behavior of RCS-C
at the shorter gene lengths is due its greater conservativeness at
these lengths. While the advantage of RCS-C over CA-P grows
with the increase in the proportion of the trait variance
explained by the covariate, its advantage over TH, SK and ER
decreases with the increase in the proportion of the trait
variance explained by the covariate.As expected, the power of
TH is close to zero when Rsq= 0%. This low power is the
direct result of the almost identical residuals obtained from
regressing the binary trait on an uncorrelated covariate. The
power of RCS-C, SK and ER increases with an increase in
Rsq. This is a result of the decreased mean square error of the
genetic coefficients induced by the increased fraction explained
by the biologically relevant covariate.
Under heterogeneity (j=0.5), CA-P performs best when
Rsq= 0%, i.e. when the covariate does not explain any fraction
of the variability in the binary trait. However, SK and ER
performs almost as well at Rsq= 0% and performs best for other
values of Rsq. At higher Rsq, TH performs better than CA-P and
almost as well as SK and ER. SK and ER have a very similar
performances with ER having, perhaps, a slight advantage at the
lower Rsq and SK at the larger Rsq. Under partial heterogeneity
(j=0.8), the relative performance of the methods is similar to the
one under heterogeneity. The only difference is that RCS-C and
TH performs improves somewhat relative to heterogeneity.
Discussion
Our findings have several implications for the choice of method
used to detect association between RVs and binary traits. First,
simple logistic regression has good performance when the
heterogeneity is not extreme. Second, SKAT and EREC methods
using permutations produce similar results and have good
performance under all scenarios we tested. However, with
permutations, the two methods are very computer intensive. If
the computational requirements for SK and ER are problematic,
the other three methods we tested (RCS-C, CA and TH) might be
useful for selecting ‘‘suggestive’’ genes to be further analyzed using
the permutation-based versions of SKAT and EREC. (SKAT with
asymptotic assumptions can also be used for selecting suggestive
signals, even though, in our experience, it can sometimes become
quite conservative - especially for binary traits at lower type I
errors and lower sample sizes.) The simple regression (RCS-C)
might be useful to select such genes, especially when one does not
expect a substantial heterogeneity of RV effects. C-alpha (CA)
without permutations (for increased speed) can be used to select
promising genes when the relevant covariates explain only a small
fraction of the trait variability. The trend and heterogeneity test
could be useful for selecting suggestive regions when the
heterogeneity of RV effects is expected to be high and the
relevant covariates are known to explain a large fraction of the
binary trait variability.
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